Zt/f2 Antibody as a Treatment for Colon Cancer
Author Information
Author(s): Yao Hang-Ping, Zhou Yong-Qing, Ma Qi, Guin Sunny, Padhye Snehal S, Zhang Rui-Wen, Wang Ming-Hai
Primary Institution: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University College of Medicine
Hypothesis
Can the monoclonal antibody Zt/f2 effectively inhibit tumor growth mediated by colon cancer cells?
Conclusion
Zt/f2 is a potential therapeutic antibody that can inhibit tumor growth in colon cancer models.
Supporting Evidence
- Zt/f2 treatment resulted in approximately 50% inhibition of tumor growth in mice.
- Combining Zt/f2 with 5-fluorouracil led to an 80% reduction in tumor growth.
- Zt/f2 specifically binds to the RON receptor, which is overexpressed in colon cancer cells.
Takeaway
The Zt/f2 antibody can help stop colon cancer cells from growing by targeting a specific protein they use to grow.
Methodology
The study involved administering the Zt/f2 antibody to mice with tumors and measuring tumor growth inhibition.
Limitations
The study only tested the antibody in animal models, and the effects in humans are not yet known.
Participant Demographics
Mice were used in the study, specifically Balb/c and athymic nude mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website